Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer

MLA

Jianshi Yu, et al. “Blocking the PAH2 Domain of Sin3A Inhibits Tumorigenesis and Confers Retinoid Sensitivity in Triple Negative Breast Cancer.” Oncotarget, vol. 7, June 2016, pp. 43689–702. EBSCOhost, https://doi.org/10.18632/oncotarget.9905.

APA

Jianshi Yu, Jace W. Jones, Lutecia Pereira, Maureen A. Kane, Melissa Fishel, Arthur Zelent, Elena Cubedo, Boris A. Leibovitch, Keely Pierzchalski, Eduardo F. Farias, Almudena Bosch, Samuel Waxman, & Nidhi Bansal. (2016). Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer. Oncotarget, 7, 43689–43702. https://doi.org/10.18632/oncotarget.9905

Chicago

Jianshi Yu, Jace W. Jones, Lutecia Pereira, Maureen A. Kane, Melissa Fishel, Arthur Zelent, Elena Cubedo, et al. 2016. “Blocking the PAH2 Domain of Sin3A Inhibits Tumorigenesis and Confers Retinoid Sensitivity in Triple Negative Breast Cancer.” Oncotarget 7 (June): 43689–702. doi:10.18632/oncotarget.9905.